Insider Transactions in Q2 2025 at Dexcom Inc (DXCM)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 26
2025
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
1,466
-1.34%
|
$124,610
$85.06 P/Share
|
|
Jun 16
2025
|
Michael Jon Brown EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
500
-0.52%
|
$41,000
$82.8 P/Share
|
|
Jun 16
2025
|
Mark G Foletta Director |
SELL
Open market or private sale
|
Indirect |
2,750
-4.63%
|
$228,250
$83.13 P/Share
|
|
Jun 16
2025
|
Nicholas Augustinos Director |
SELL
Open market or private sale
|
Indirect |
3,672
-9.9%
|
$301,104
$82.8 P/Share
|
|
Jun 13
2025
|
Nicholas Augustinos Director |
SELL
Open market or private sale
|
Indirect |
2,618
-6.59%
|
$212,058
$81.69 P/Share
|
|
May 27
2025
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
6,184
-5.34%
|
$525,640
$85.11 P/Share
|
|
May 23
2025
|
Michael Jon Brown EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-9.47%
|
$840,000
$84.28 P/Share
|
|
May 22
2025
|
Jon Coleman EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
68,738
+50.0%
|
-
|
|
May 08
2025
|
Rimma Driscoll Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,074
+30.22%
|
-
|
|
May 08
2025
|
Eric Topol Director |
BUY
Bona fide gift
|
Indirect |
2,618
+0.68%
|
-
|
|
May 08
2025
|
Eric Topol Director |
SELL
Bona fide gift
|
Direct |
2,618
-100.0%
|
-
|
|
May 08
2025
|
Steven R Altman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,037
+50.0%
|
-
|
|
May 08
2025
|
Steven R Altman Director |
BUY
Bona fide gift
|
Indirect |
2,613
+4.27%
|
-
|
|
May 08
2025
|
Steven R Altman Director |
SELL
Bona fide gift
|
Direct |
2,613
-100.0%
|
-
|
|
May 08
2025
|
Richard Alexander Collins Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,074
+50.0%
|
-
|
|
May 08
2025
|
Richard Alexander Collins Director |
BUY
Bona fide gift
|
Indirect |
2,632
+5.9%
|
-
|
|
May 08
2025
|
Richard Alexander Collins Director |
SELL
Bona fide gift
|
Direct |
2,632
-100.0%
|
-
|
|
May 08
2025
|
Mark G Foletta Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,731
+50.0%
|
-
|
|
May 08
2025
|
Mark G Foletta Director |
BUY
Bona fide gift
|
Indirect |
2,973
+4.77%
|
-
|
|
May 08
2025
|
Mark G Foletta Director |
SELL
Bona fide gift
|
Direct |
2,973
-100.0%
|
-
|
|
May 08
2025
|
Nicholas Augustinos Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,046
+50.0%
|
-
|
|
May 08
2025
|
Nicholas Augustinos Director |
BUY
Bona fide gift
|
Indirect |
2,618
+6.19%
|
-
|
|
May 08
2025
|
Nicholas Augustinos Director |
SELL
Bona fide gift
|
Direct |
2,618
-100.0%
|
-
|
|
May 08
2025
|
Bridgette P Heller Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,046
+15.25%
|
-
|
|
May 08
2025
|
Karen M Dahut Director |
BUY
Bona fide gift
|
Indirect |
2,613
+12.81%
|
-
|
|
May 08
2025
|
Karen M Dahut Director |
SELL
Bona fide gift
|
Direct |
2,613
-100.0%
|
-
|
|
May 08
2025
|
Kyle Malady Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,192
+18.2%
|
-
|
|
May 08
2025
|
Renee D Gala Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,074
+31.98%
|
-
|